Bedinvetmab Reference: HY-P99297 Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs.
Mavrilimumab Reference: HY-P99031 Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death.
Ripertamab Reference: HY-P99952 Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).
Dilpacimab Reference: HY-P99852 Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer.
Loading Control Antibody Panel (Actin, beta Tublin, Histone H3, GAPDH) Reference: ARG30270 Loading Control antibody; GAPDH antibody; beta Actin antibody; beta Tubulin antibody; Histone H3 antibody
Anti-Mouse CD209b Antibody Reference: HY-P99122 Anti-Mouse CD209b Antibody is an anti-mouse CD209b IgG1 antibody inhibitor derived from the host Armenian Hamster.
Mitochondrial Marker Antibody Panel (Cytochrome C, COX4, HSP60) Reference: ARG30271 Mitochondrial Marker antibody; COX4 antibody; Hsp 60 antibody; Cytochrome C antibody
Nadunolimab Reference: HY-P99235 Nadunolimab is a human monoclonal IgG1 antibody targeting IL1RAP. Nadunolimab blocks IL-1α and IL-1β signaling and triggering antibody-dependent cellular cytotoxicity. Nadunolimab can be used in research of cancer.